tiprankstipranks
Arovella Therapeutics Limited (AU:ALA)
:ALA
Australian Market

Arovella Therapeutics Limited (ALA) Financial Statements

Compare
11 Followers

Arovella Therapeutics Limited Financial Overview

Arovella Therapeutics Limited's market cap is currently AU$207.51M. The company's EPS TTM is AU$-0.009; its P/E ratio is ―; Arovella Therapeutics Limited is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is AU
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 17.00KAU$ 405.90KAU$ 295.81KAU$ 257.35KAU$ 532.69K
Gross ProfitAU$ -25.98KAU$ -3.00MAU$ 88.75KAU$ 34.60KAU$ 331.72K
Operating IncomeAU$ -10.81MAU$ -9.68MAU$ -7.59MAU$ -3.75MAU$ -3.98M
EBITDAAU$ -8.83MAU$ -10.37MAU$ -7.87MAU$ -4.99MAU$ -3.40M
Net IncomeAU$ -8.75MAU$ -10.18MAU$ -8.62MAU$ -5.05MAU$ -9.94M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 12.71MAU$ 5.18MAU$ 6.07MAU$ 6.72MAU$ 977.47K
Total AssetsAU$ 13.28MAU$ 5.47MAU$ 9.21MAU$ 10.69MAU$ 6.71M
Total DebtAU$ 0.00AU$ 0.00AU$ 144.80KAU$ 79.23KAU$ 85.46K
Net DebtAU$ -12.71MAU$ -5.18MAU$ -5.93MAU$ -6.64MAU$ -892.01K
Total LiabilitiesAU$ 2.06MAU$ 1.69MAU$ 1.60MAU$ 1.71MAU$ 2.57M
Stockholders' EquityAU$ 11.23MAU$ 3.78MAU$ 7.62MAU$ 8.98MAU$ 4.14M
Cash Flow
Free Cash FlowAU$ -7.04MAU$ -6.40MAU$ -6.83MAU$ -4.06MAU$ -3.27M
Operating Cash FlowAU$ -6.91MAU$ -6.40MAU$ -6.27MAU$ -3.54MAU$ -2.88M
Investing Cash FlowAU$ -179.34KAU$ 95.42KAU$ -566.00KAU$ -514.55KAU$ -388.42K
Financing Cash FlowAU$ 14.61MAU$ 5.41MAU$ 6.19MAU$ 9.80MAU$ -63.94K
Currency in AUD

Arovella Therapeutics Limited Earnings and Revenue History

Arovella Therapeutics Limited Debt to Assets

Arovella Therapeutics Limited Cash Flow

Arovella Therapeutics Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis